Providing a basic explanation of some of the major hurdles encountered by cancer researchers, Dr. Feilotter, a cancer researcher and molecular geneticist, provides clarity around the growing recognition within the scientific community about the complexity of this disease. While many people think of cancer as being a very common illness, this talk explores the concept that cancer is actually extremely rare - so rare, in fact, that it is not easy to study. The slippery genetics that underlies the development and evolution of tumours is described, leading us to the conclusion that perhaps we need to reframe our questions. Dr. Feilotter is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, where she maintains an active program dedicated to the assessment of methods for
biomarker validation and to the transfer of clinically actionable molecular information to the clinical setting. She has a special interest in the integration of platforms designed to support studies of human DNA, RNA, and protein biomarkers. Her roles as Service Chief of Kingston Health Sciences Center’s Laboratory Genetics and Director of the Queen’s Genomics facility allow her to focus on methods to bridge the gap between research and clinical application of biomarker findings. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at www.ted.com/tedx
27 июн 2024
